Vanguard Group Inc's Strategic Acquisition of Edwards Lifesciences Corp Shares
Edwards Lifesciences Earnings Preview: What to Expect
Wells Fargo Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $80
Analysts Conflicted on These Healthcare Names: TransMedics Group (TMDX), Vertex Pharmaceuticals (VRTX) and Edwards Lifesciences (EW)
TD Cowen Downgrades Edwards Lifesciences(EW.US) to Hold Rating, Cuts Target Price to $70
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Tandem Diabetes Care (TNDM) and BioMarin Pharmaceutical (BMRN)